Amarin Corp PLC (NAS:AMRN)
$ 0.704 -0.0208 (-2.93%) Market Cap: 289.25 Mil Enterprise Value: -10.54 Mil PE Ratio: 0 PB Ratio: 0.53 GF Score: 43/100

Amarin Corporation PLC KOL Webinar Transcript

Nov 07, 2022 / NTS GMT
Release Date Price: $1.31 (+11.97%)
Steven B. Ketchum
Amarin Corporation plc - President of Research & Development, Executive VP and Chief Scientific Officer

Thank you all for joining what we believe will be a stimulating and useful discussion about key cardiovascular therapeutic data presented at this year's American Heart Association 2022 Scientific Sessions and their impact on patient care in both the United States and Europe. We know you are very busy, and we are grateful for your perspectives and input on data presented at the AHA Scientific Sessions. I'm Dr. Steven Ketchum, Executive Vice President, President of R&D and Chief Scientific Officer at Amarin.

Nabil Abadir
Amarin Corporation plc - Senior VP, Chief Medical Officer & Head of Global Medical Affairs

And I'm Nabil Abadir, I'm the Senior Vice President and Chief Medical Officer at Amarin. Turning to our panel. Can I ask each of our participant to please briefly introduce yourself, starting with Dr. Cory?

Payal Kohli

Good morning, everyone. I'm Dr. Payal Kohli. I'm a noninvasive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot